Patient Rights at a Stem Cell Clinic: What You Should Know

Patient rights are the basic expectations you can have when you receive care from any licensed clinician or clinic. They generally include clear information about what is being offered, the freedom to ask questions, the ability to get a second opinion, and the right to say no or stop at any point.

At a stem cell clinic, these rights matter even more because the field is mixed. Blood-forming stem cell transplants from cord blood or bone marrow, used for certain cancers and blood disorders, are the clearly FDA-approved use. By contrast, stem cell, MSC, bone marrow aspirate, adipose-derived, umbilical cord or Wharton's jelly, and exosome products marketed for joints, back pain, sports injuries, skin, anti-aging, or hair loss are generally not FDA-approved for those uses.

The FDA has publicly warned people about unapproved stem cell clinics and products. Reported risk categories include infection, immune reaction, tumor formation at the injection site, and permanent injury when unapproved products are injected into the eye or spine. Knowing your rights helps you ask about these things before you decide anything.

Informed consent has long been a cornerstone of medical care. Traditionally, a clinician explains a proposed treatment, what it involves, its risks and possible benefits, and the alternatives, and the patient then decides freely whether to go ahead.

For approved treatments, such as blood-forming stem cell transplants for certain cancers and blood disorders, this conversation typically happens within established medical settings with defined oversight. For experimental uses, legitimate access has traditionally come through registered clinical trials, which have their own review and consent processes.

Patients have also traditionally been able to seek a second opinion, request their records, and raise concerns with the clinic, a state medical board, or the FDA's MedWatch safety reporting program. These are general routes, and details vary by location.

The right provider may help by slowing the process down and making sure you understand your options. A visit generally begins with an evaluation of your history and concerns, followed by a plain-language conversation. Only a licensed clinician can decide what is appropriate for you after that evaluation.

Good informed consent discussions typically cover this checklist, which is not a legal template: the exact product and its FDA status; the specific risks; a realistic chance of benefit; alternatives, including doing nothing; total cost disclosure in writing; and your right to walk away. This page is educational content and is not a consent form.

Watch for red flags: guarantees of results, 'cure' or 'regrow' language, refusal to name the product or its FDA status, pressure to decide quickly, and discouraging a second opinion. Treatment abroad carries materially higher risk because safety, sourcing, and regulatory standards differ and complications are harder to address from a distance, so a vetted domestic provider is a safer first step. You can also search ClinicalTrials.gov for registered clinical trials as a route to legitimate experimental care.